skip to the main content area of this page

May 2020 – UNODC: CND decision on international control of two fentanyl analogues enters into force - remaining decisions will enter into force in November 2020.

VIENNA, Austria - May 2020:  The decision adopted by the Commission on Narcotic Drugs (CND) during its 63rd Session from 2 to 6 March 2020 to add Crotonylfentanyl and Valerylfentanyl to Schedule I of the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, was communicated by the Secretary-General on 7th of May 2020 to all States Members of the United Nations, to non-member States Parties to the Conventions, to the World Health Organization and to the International Narcotics Control Board and thereby entered into force on that date.

The decision adopted by the CND to add DOC (2,5-dimethoxy-4-chloroamphetamine) to Schedule I, AB-FUBINACA5F-AMB-PINACA5F-MDMB-PICA4F-MDMB-BINACA4-chloromethcathinoneN-ethylhexedroneα-pyrrolidinohexanophenone to Schedule II and flualprazolametizolam to Schedule IV of the Convention on Psychotropic Substances of 1971 will come into force on 3rd November 2020.  Similarly, the decision to include the precursors methyl alpha-phenylacetoacetate (MAPA) (including its optical isomers) in Table I of the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988, will enter into force on 3rd November 2020.

For further information please see:

EWA newsclip: Twelve substances and one precursor "scheduled" at the 63rd Session of the Commission on Narcotic Drugs

EWA newsclip: World Health Organization recommends 12 NPS for scheduling

CND International Drug Conventions

English Advance version of the CND report

go back